Status:
UNKNOWN
The Effect of Remote Diagnosis and Treatment on 24 Hour Ambulatory Blood Pressure Rhythm of OSA Patients
Lead Sponsor:
Peking University People's Hospital
Conditions:
Sleep Apnea, Obstructive
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Epidemiological studies have shown that OSA is closely related to the occurrence and development of cardiovascular diseases, especially hypertension. At present, there are 66 million patients with mod...
Detailed Description
Patients who came to the hospital for snoring were randomly divided into the telemedicine group and the outpatient group, and the ambulatory blood pressure values and rhythm changes of the two groups ...
Eligibility Criteria
Inclusion
- Suspected OSA and recommended to sleep center for HSAT monitoring;
- Voluntary and signed informed consent;
- Voluntary and can complete 24-hour ambulatory blood pressure monitoring and blood sample collection at the first visit and at 3 months follow-up;
- Access to the Internet, email and phone calls;
- Lived in Beijing for the last three months (subjects randomly assigned to the outpatient treatment group were able to travel to and from the sleep center);
- Fluent Chinese expression;
Exclusion
- Blood pressure cuff should not be used (e.g., circumference of upper arm \> 55cm, history of breast cancer, structural lesions of upper limb);
- Has been treated with a CPAP or oral appliance;
- Cardiac insufficiency, NYHA classes III-IV;
- Clear central sleep apnea (AHI≥15 times/hour, central events \> 50%);
- Expected life span \< 2 years;
- Pregnant women;
- History of kidney failure or kidney transplantation;
- Attention deficit hyperactivity disorder, use of wakefulness drugs;
- Less than 5 hours of sleep per night on weekdays combined with other sleep problems (e.g., shift work, night shift, circadian rhythm disturbance);
- Oxygen is needed when awake or sleeping;
- Unstable condition: unstable angina pectoris, uncontrolled hypertension, severe COPD, tumor progression, or unstable mental illness;
Key Trial Info
Start Date :
October 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06064630
Start Date
October 15 2023
End Date
August 15 2024
Last Update
October 3 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.